메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Hongyi Wei (Center for Reproductive Medicine Peking University Third Hospital Beijing China) Ningning Pan (Center for Reproductive Medicine Peking University Third Hospital Beijing China) Wen Zhang (Center for Reproductive Medicine Peking University Third Hospital Beijing China) Guangwu Xiong (Peking University International Hospital Beijing China) Wenping Guo (Peking University International Hospital Beijing China) Zhe Dong (Peking University International Hospital Beijing China) Caihong Ma (Center for Reproductive Medicine Department of Obstetrics and Gynecology Peking University)
저널정보
대한부인종양학회 Journal of Gynecologic Oncology Journal of Gynecologic Oncology Vol.34 No.2
발행연도
2023.3
수록면
1 - 15 (15page)
DOI
https://doi.org/10.3802/jgo.2023.34.e36

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Objective: To conduct a systematic review and meta-analysis of studies evaluating theoncological and fertility outcomes of early-stage endometrial cancer (EC) treated with thelevonorgestrel-releasing intrauterine system (LIUS)-based regimens. Methods: The Meta-analyses Of Obser vational Studies in Epidemiology statement for meta-analyses was followed. Searches were conducted on MEDLINE, Embase, PubMed, Preprints,and the Cochrane Central Register of Controlled Trials from Januar y 1990 to August 4, 2022. The Joanna Briggs Institute Critical Appraisal Checklist was used for quality assessment. Theprimar y endpoint was the complete response (CR) rate and the secondar y endpoints wererelapse, pregnancy, and live birth rate. Results: A total of 25 studies (821 women) were included. The CR rate of LIUS-basedregimens was 63.4% (95% confidence inter val [CI]=52.3%–73.2%), with 29.6% (95%CI=23.3%–36.8%) of cases experiencing recurrence during follow-up. In sensitivity analyses,patients younger than 45 years of age with a body mass index <30 kg/m2 who were treatedwith LIUS-based regimens achieved a high CR rate of 84.6% (95% CI=80.3%–88.1%) overa median follow-up of more than 24 months. Overall pregnancy and live birth rates were37.9% (95% CI=24.1%–53.9%) and 39.3% (95% CI=24.0%–57.0%), respectively. No statisticaldifferences were apparent in CR or relapse rates among the LIUS+GnRH agonist, LIUS+oralprogesterone, or hysteroscopic resection followed by LIUS subgroups. Conclusion: LIUS-based therapies are viable for the conser vative management of early-stageendometrioid EC on CR and fertility outcome.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0